Full-Time

Clinical Solutions Manager

Posted on 3/30/2025

Becton Dickinson

Becton Dickinson

10,001+ employees

Global medical technology and diagnostics provider

Compensation Overview

$99.6k - $164.3k/yr

Senior, Expert

Indianapolis, IN, USA + 4 more

More locations: Houston, TX, USA | California, USA | Chicago, IL, USA | Monroe, GA, USA

Candidates must be based in specific states, including Georgia, Illinois, Texas, Indiana, and California, with a minimum of 4 days in-office presence required per week.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Becton Dickinson referral from your network.

đź’ˇ

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Registered Nurse with a Bachelor's Degree, degree level qualification, or equivalent combination of education and experience.
  • Travel up to 75% per week, including overnight travel.
Responsibilities
  • Foster a continually evolving partnership between multiple hospital departments, C-Suite, UCC National Accounts, and Regional Sales leaders from Acute Care and TTM businesses.
  • Maintain knowledge and expertise as a TTM and Acute Care solution expert, i.e., products (Artic Sun, Arctic Gel Pads, Sensica, BBS, SureStep products, Foley Alternatives, etc.) and BD clinical value wedge (Analytics Portal, EMR interoperability, BD Acute Academy, Clinical Connect Program, Virtual Reality, etc.).
  • Leverage TTM Solution and Zero-In Lifecycle Assessment data to lead and partner in change management activities associated with process improvement recommendations from data insights gained.
  • Effectively deliver presentations and reports to various audiences: Nursing Leadership, C-Suite, Department Directors, Medical Directors, and Supply Chain.
  • Collaborates with the Regional Sales team during quarterly Territory Business Planning and WIN Room Discussions to discuss facilitating strategy for current and competitive Key Accounts.
  • Network and participate in local, state, and national associations, i.e., AHA, SCCM, NANN, AAP, APIC, AACN, and WOCN.
  • Interact with customer committees as requested (i.e., product, safety, infection control, policy committees, code blue, critical care, emergency medicine, and BioMed).
  • Maintains a strong presence on TTM and Acute Care regional teams to assist in strategizing and implementing the UCC clinical solutions to our key accounts, along with providing ongoing clinical support for regional sales team members during account business planning.
  • Supports UCC Clinical Managers' continued development through field-rides, consistent communication, collaboration and feedback as needed.

BD (Becton, Dickinson and Company) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three main areas: BD Medical, which focuses on medication management and delivery; BD Life Sciences, which provides products for safe collection and transport of diagnostic specimens; and BD Interventional, which offers devices for minimally invasive surgeries. The company generates revenue by selling medical devices, laboratory equipment, and diagnostic products. BD stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and increasing safety and efficiency in healthcare.

Company Size

10,001+

Company Stage

IPO

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...

INACTIVE